Entero Healthcare Solutions' Q2 FY 2025-26 Quarterly Results

Result Summary

• Entero Healthcare Solutions Ltd reported a 11.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 20.1%.
• Its expenses for the quarter were up by 11.5% QoQ and 19.9% YoY.
• The net profit increased 21.1% QoQ and increased 40.6% YoY.
• The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 7.25 during Q2 FY 2025-26.

Financial Statments for Q2 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Entero Healthcare Solutions Ltd is a company operating in the healthcare sector. It primarily focuses on providing a range of healthcare solutions and services, including medical supplies and pharmaceutical distribution. While specific information about recent developments for Entero Healthcare Solutions Ltd is not available, companies in this industry typically engage in activities such as expanding their product line, entering new markets, or forming strategic partnerships to enhance their service offerings. Entero Healthcare Solutions Ltd is committed to delivering quality services within the healthcare ecosystem, contributing to efficient healthcare delivery.

Revenue

In the second quarter of the fiscal year 2026 (Q2FY26), Entero Healthcare Solutions Ltd reported a total income of ₹1575.74 crores. This marks an 11.8% increase from the previous quarter (Q1FY26), where the total income stood at ₹1409.64 crores. Comparing year-over-year performance, the total income saw a significant rise of 20.1% from ₹1311.97 crores in Q2FY25 to the current quarter's figure. These increases indicate a robust growth in revenue, reflecting the company's ability to enhance its income streams over both short and long-term periods.

Profitability

The company's profitability metrics for Q2FY26 show positive growth. The profit before tax was ₹44.62 crores, up by 22.7% from ₹36.36 crores in Q1FY26, and a year-over-year increase of 28.3% from ₹34.78 crores in Q2FY25. The tax expense for Q2FY26 was ₹8.02 crores, which is a 30.8% increase from the previous quarter and a decrease of 8.2% compared to the same quarter last year. Ultimately, the profit after tax for Q2FY26 was ₹36.60 crores, reflecting a quarterly growth of 21.1% and a substantial year-over-year growth of 40.6%. Earnings per share (EPS) also improved, with Q2FY26 showing ₹7.25, up 13.6% from the previous quarter's ₹6.38 and a year-over-year increase of 33.8% from ₹5.42 in Q2FY25.

Operating Metrics

The total expenses for Entero Healthcare Solutions Ltd in Q2FY26 were reported at ₹1531.11 crores, which represents an 11.5% increase from Q1FY26's ₹1373.28 crores and a 19.9% increase from ₹1277.19 crores in Q2FY25. This indicates a consistent upward trend in operating costs over the quarters. Despite the rise in expenses, the company has managed to maintain a positive trajectory in profitability metrics, such as profit before tax and profit after tax. The efficient management of operating expenses relative to income growth has been a notable aspect of the company's financial performance for this quarter.